Electroconvulsive therapy vs. paroxetine in treatment-resistant depression - A randomized study

Acta Psychiatrica Scandinavica

Volumn 96, Issue 5, 1997, Pages 334-342

  Folkerts, H W ^a   Michael, N ^a   Tolle R ^a   Schonauer, K ^a   Mucke S ^b   Schulze Monking H ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b St Rochus Psychiatric Hospital   (Germany)

Author keywords

Electroconvulsive therapy; Paroxetine; Treatment resistant depression

Indexed keywords

PAROXETINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESEARCH; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0030695962     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb09926.x     Document Type: Article

References (38)

1. ROOSE SP. Methodological issues in the diagnosis, treatment, and study of refractory depression. In: ROOSE SP, GLASSMAN AH, ed. Treatment strategies for refractory depression. Washington, DC, USA: American Psychiatric Press, 1990: 3-9.
2. NIERENBERG AA, AMSTERDAM JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 1990: 51 (Suppl. 6): 39-47.
3. MÖLLER HJ. Non-response to antidepressants: risk factors and therapeutic possibilities. Nervenarzt 1991: 62: 658-669.
4. BURROWS GD, NORMAN TR, JUDD FK. Definition and differential diagnosis of treatment-resistant depression. Int Clin Psychopharmacol 000 1994: 9 (Suppl. 2): 5-10.
5. ABRAMS R. Electroconvulsive therapy, 2nd edn. Oxford: Oxford University Press, 1992.
6. FINK M. Convulsive therapy: theory and practice. New York: Raven Press, 1979.
7. American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993: 150: Suppl. 4: 1-23.
8. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994: 151: Suppl. 12: 1-31.
9. FINK M. Who should get ECT? In: COFFEY CE, ed. The clinical science of ECT. Washington, DC: American Psychiatric Press, 1993: 3-15.
10. FREEMAN CP. The ECT handbook. The second report of the Royal College of Psychiatrists Special Commitee on ECT. London: Gaskell, 1995.
11. SACKEIM HA. Continuation therapy following ECT: directions for future research. Psychopharmacol Bull 1994: 30: 501-521.
12. CHRISTIANSEN PE, BEHNKE K, ÖHRSTRÖM JK, BORK-RASMUSSEN H, NILSSON J. Paroxetine and amitriptyline in the treatment of depression in general practice. Acta Psychiatr Scand 1996: 93: 158-163.
13. FEIGHNER JP, BOYER WF. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. J Clin Psychiatry 1992: 53 (Suppl. 2): 44-47.
14. JOFFE RT, LEVITT AJ, SOKOLOV STH, YOUNG LT. Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 1996: 57: 114-115.
15. KASPER S, HEIDEN A. Do SSRIs differ in their anti-depressant efficacy? Hum Psychopharmacology 1995: 10 (Suppl. 3): 163-172.
16. BEALE MD, KELLNER CH, PRITCHETT JT, BERNSTEIN HJ, BURNS CM, KNAPP R. Stimulus dose titration in ECT: a 2-year clinical experience. Convuls Ther 1994: 10: 171-176.
17. KUHS H. Degrees of treatment resistance in depressive disorders on the basis of somatotherapeutic trails. Nervenarzt 1995: 66: 561-567.
18. Keller MB, Lavori PW, Rice J. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 1992: 1431: 24-28.
19. SACKEIM HA, PRUDIC J, DEVANAND DP, DECINA P, KERR B, MALITZ S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacology 1990: 10: 96-104.
20. DE CAROLIS V, GIBERTI F, ROCTATAGLIA G. Imipramina ed elettroshock nella terapia delle depressioni: analisi clinico-statisica dei risutanti in 437 casi. Sistena Nervosa 1964: 1: 28-42.
21. Medical Research Council. Clinical trial of the treatment of depressive illness. Br Med J 1965: 5439: 881-886.
22. BRATFOS O, HAUG JO. Electroconvulsive therapy and antidepressant drugs in manic depressive disease. Acta Psychiatr Scand 1965: 41: 588-596.
23. MANDEL MR, WELCH CA, MIESKE M. Prediction of response to ECT in tricyclic-intolerant or tricyclic-resistant depressed patients. McLean Hosp J 1977: 2: 203-209.
24. DAVIDSON J, MCLEOD M, LAW-YONE B, LINNOILA M. Comparison of ECT and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 1978: 35: 639-644.
25. MEYENDORF R, BENDER W, BAUMANN E, ATHEN D, ORTLIEB S. (1980) Vergleichende Untersuchung zur unilateralen und bilateralen Elektrokrampftherapie. Arch Psychiatr Nervenkr 1980: 229: 89-112.
26. PAUL SM, EXTEIN I, CALIL HM. Use of ECT with treatment resistant depressed patients at the National Institute of Mental Health. Am J Psychiatry 1981: 138: 486-489.
27. MARKOWITZ J, BROWN R, SWEENEY J, MANN JJ. Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatry 1977: 144: 1025-1029.
28. BLACK DW, WINOKUR G, NASRALLAH A. The treatment of depression: electroconvulsive therapy vs. antidepressants. A naturalistic evaluation of 1496 patients. Compr Psychiatry 1987: 28: 169-182.
29. MAGNI G, FISMAN M, HELMES E. Clinical correlates of ECT resistant depression in the elderly. J Clin Psychiatry 1988: 49: 405-407.
30. SOLAN WJ, KHAN A, AVERY D, COHEN S. Psychotic and non-psychotic depression: comparison of response to ECT. J Clin Psychiatry 1988: 49: 97-99.
31. DINAN TG, BARRY S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989: 80: 97-100.
32. PRUDIC J, SACKEIM HA, DEVANAND DP. Medication resistance and clinical response to ECT. Psychiatr Res 1990: 31: 287-296.
33. DIETZFELBINGER T. Elektrokrampftherapie als ultima ratio bei Antidepressiva-NonRespondern. In: MÖLLER HJ, ed, Therapieresistenz unter Antidepressivatherapie. Berlin: Springer, 1990: 167-185.
34. PRUDIC J, HASKETT RF, MULSANT B et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996: 153: 985-992.
35. FOLKERTS H. The ictal EEG as a marker for the efficacy of ECT. Eur Arch Psychiatry Neurol Neurosci 1996: 246: 155-164.
36. LAURITZEN L, ODGAARD K, CLEMMESEN L et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996: 94: 241-251.
37. HAYAKAWA H, OKAMOTO Y, SHIMIZU M, NISHIDA A, MOTOHASHI N, YAMAWAKI S. Single or repeated treatments with electroconvulsive shock increase the number of serotonin uptake binding sites in the frontal cortex. Neuropsychobiology 1995: 31: 1-5.
38. SHAPIRA B, LERER B, KINDLER S et al. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression. Br J Psychiatry 1992: 160: 223-229.